Eye research paves way for more successful cornea transplants

July 6, 2012, University of Reading

(Medical Xpress) -- Scientists at the University of Reading have made a significant breakthrough in cornea transplant research that could make future procedures more successful.

Amniotic membrane (AM) has been used in the clinical treatment of eye disorders for over a decade. During this time it has been seen as an excellent natural surface on which to grow corneal stem cells, despite the fact that its structural and biological properties have been poorly understood.

Furthermore, regardless of AM's many reported successful ophthalmic outcomes, the resulting clinical efficacy has lacked predictability - its success rate, when used in conjunction with stem cells, ranges from 46% to 100%.

Researchers from Reading have now shown that the location of the AM, relative to the placenta, plays a crucial part in its success as a . AM taken nearer to the placenta is stiffer than that taken from further away, and this difference in mechanical properties dramatically effects the functionality of the stem cells. This is particularly pertinent as the underlying clinical reason for using AM is that the transplanted cells should remain in a relatively unchanged state to maximize their clinical effect.

Dr Che Connon, from Reading School of Pharmacy, said: "Our work suggests that clinical results could be improved by using AM collected from an area close to the placenta, or by normalizing the substrate's (stiffness), chemically, prior to use.

"Until now no consideration has been given to the origin of the AM, relative to the , when used as a surface for the expansion of prior to transplantation. Our new research should improve the success of the procedure."

Explore further: Engineered cornea more resistant to chemical injury

More information: The paper, The mechanical properties of amniotic membrane influence its effect as a biomaterial for ocular surface repair, by Bo Chen, Roanne R. Jones, Shengli Mi, James Foster, Simon G. Alcock, Ian W. Hamley and Che J. Connon, appears in Soft Matter, DOI:10.1039/C2SM26175H

Related Stories

Engineered cornea more resistant to chemical injury

May 28, 2012
(Medical Xpress) -- A new study from the University of Reading has established that a prosthetic cornea made from human cells is the best model for testing how irritants and toxins cause eye injuries.

Stem cell research could prevent premature births

September 7, 2011
Researchers from the University of Reading have developed the first fully tissue-engineered fetal membrane from human stem cells that could significantly reduce the number of premature births.

Two patients in Scotland get stem cell transplants to treat blindness

May 22, 2012
(Medical Xpress) -- Two people in Scotland have received stem cell transplants into their eyes in a clinical trial that is aimed at restoring vision in people that suffer some degree of blindness due to damage to the cornea. ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.